8-K - TScan Therapeutics, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

TScan Therapeutics announced the resignation of Vice President of Finance Leiden Dworak and the appointment of CFO Jason A. Amello as principal accounting officer, effective April 10, 2026.

Key Takeaways

1Leiden Dworak resigned as Vice President of Finance and principal accounting officer, effective April 10, 2026.

2The resignation was not due to any disagreements with the company regarding operations, policies, or practices.

3CFO Jason A. Amello was appointed as the new principal accounting officer, effective April 10, 2026.

4Mr. Amello will not receive additional compensation for assuming the principal accounting officer role.

Current Report Details

Event Type

Management Change

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. | |---|

Management Change

Executive & Director Changes

Leiden Dworak

Vice President of Finance and principal accounting officer

Resignation

Effective: 2026-04-10

Personal decision

Jason A. Amello

Chief Financial Officer, principal financial officer, and principal accounting officer

Appointment

Effective: 2026-04-10

Exhibits (1)

8-K